View in EDS

Adjuvant trastuzumab in HER2-positive breast cancer.

Saved in:

Bibliographic Details
Title:	Adjuvant trastuzumab in HER2-positive breast cancer.
Authors:	Collins I (AUTHOR), Francis P (AUTHOR), Mileshkin L (AUTHOR), Collins, Ian (AUTHOR), Francis, Prudence (AUTHOR), Mileshkin, Linda (AUTHOR)
Source:	New England Journal of Medicine. 2/16/2012, Vol. 366 Issue 7, p664-666. 4p.
Database:	Academic Search Ultimate

Description
ISSN:	00284793
DOI:	10.1056/NEJMc1112823